Let's consider statins, a medication used by millions of Americans. Before we push to get more patients treated, perhaps we should get the ones already being treated to take their medications properly (if at all).
The FDA used Tipping Point Analysis to show that an important study of cholesterol-lowering medications is incorrect. So who got it wrong? The FDA or the New England Journal of Medicine, which peer-reviewed the work?
Not only are eggs not the villainous promoters of heart disease they've been cracked up to be, they may actually help promote heart health. An investigation into the subtypes of LDL and HDL cholesterol found that eating as many as 3 eggs per day can have a positive influence — at least in younger, healthy people.
A recent study on how olive oil affects HDL and LDL (good and bad cholesterol in your body) has us wondering.. Is all cholesterol created equal?
A new report highlights the number of Americans who are candidates for reducing their risk of heart and vascular disease because they have elevated LDL levels. It also reveals how many of them are actually taking lipid-lowering drugs, such as statins. And as it turns out, it's not enough.
Walnuts seem to be making their way into the news with increasing frequency. A recent study found that walnuts significantly aided diet quality, while helping the lining of the walls of blood vessels and improving total and LDL ("bad") cholesterol levels.
In 2013, a combined panel of cardiology and lipid experts under the aegis of the American College of Cardiology and the American Heart Association (ACC/AHA) published revised recommendations for candidates for statin therapy to reduce the risk of cardiovascular events (heart attack, stroke or sudden death due to coronary artery disease: CVD). Rather than focusing, as always before (e.g. the ATP-III published in 2003) on lipid levels, LDL especially, the new report emphasized overall heart risk using other parameters including age, weight, blood pressure, and diabete
A new series of articles by the NYTimes Gina Kolata focuses on improvements in dealing with emergency cardiac events, and indeed the progress has been remarkable. But that s not the solution to reducing the toll of our nation s leading killer: coronary disease.
Follow-up on two of our recent, important Dispatch items. California s Assembly has cleared the next-to-last legislative hurdle toward removing the state s non-medical exemptions for children s vaccinations. And an FDA panel has approved overwhelmingly a new type of cholesterol-lowering medication.
As reported by Ed Mr. Pharmaceuticals Silverman, in yesterday s Wall Street Journal, there may be a new paradigm for significantly lowering LDL (bad) cholesterol, and reducing heart disease.
A new scientific statement in the journal Stroke, published by the American Heart Association (in concert with the American Stroke
The American Heart Association and the American College of Cardiology surprised many doctors and patients by issuing controversial new guidelines for reducing cardiovascular risk factors,